Scientists create library of mutant bacteria to study antibiotic resistance

Modern medicine depends on antibiotics to treat infections by disabling targets inside bacterial cells. Once inside these cells, antibiotics bind to certain sites on specific enzyme targets to stop bacterial growth.

BioMarin strikes cooperation deal with activist investor Elliott, sets up review committee and adds board members

More than a month after activist investor Elliott Investment Management bought a $1 billion stake in BioMarin, the two have reached a deal to cooperate

December 22, 2023

Pharma’s ethically questionable sites essentially sell drugs directly to consumers

Want to self-prescribe a prescription drug? No problem! Some of the largest pharmaceutical companies in the U.S. are piloting websites that essentially sell their drugs

November 6, 2024

AI model GPT-4 exceeds unspecialized doctors’ ability to assess eye problems

The clinical knowledge and reasoning skills of GPT-4 are approaching the level of specialist eye doctors, a study led by the University of Cambridge has

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.